These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 769903)

  • 1. T lymphocytes in kidney allograft recipients.
    Tursz T; Fournier C; Kreis H; Crosnier J; Bach JF
    Br Med J; 1976 Apr; 1(6013):799-801. PubMed ID: 769903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
    Daudu P; Wright K; Geelhoed GW
    Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Focus on cutaneous host-defense failure in transplant recipients.
    Hersh EM; Freireich EJ
    JAMA; 1974 Jul; 229(4):457-8. PubMed ID: 4600401
    [No Abstract]   [Full Text] [Related]  

  • 6. Total and active T cell dynamics in renal allograft recipients.
    Kerman RH; Geis WP
    Surgery; 1976 Apr; 79(4):398-407. PubMed ID: 769220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a rosette inhibition test in renal allotransplantation.
    Munro A; Bewick M; Manuel L; Cameron JS; Ellis FG; Boulton-Jones M; Ogg CS
    Br Med J; 1971 Jul; 3(5769):271-6. PubMed ID: 4934045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T- and B-lymphocytes in patients with kidney transplants].
    Meyer HJ; Wonigett K; Pichlmayr R
    Langenbecks Arch Chir; 1975; Suppl():157-60. PubMed ID: 1107702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective monitoring and modulation of immune reactivity in allograft recipients.
    Thomas F; Lee HM; Thomas J; Mendez-Picon G
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():20-6. PubMed ID: 801063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T-rosette and rosette inhibition test with antilymphocyte globulin following kidney transplantation].
    Philipp H; Scholz D; Menzel G
    Z Urol Nephrol; 1977 May; 70(5):331-8. PubMed ID: 331746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and alterations of lymphocyte subpopulations in renal allograft recipients.
    Chatterjee SN; Gershwin ME; Eckles D
    Transplant Proc; 1979 Mar; 11(1):374-8. PubMed ID: 377659
    [No Abstract]   [Full Text] [Related]  

  • 12. Discrepancy between PHA responsiveness and quantitative estimates of T-cell numbers in human peripheral blood during chronic renal failure and immunosuppression after transplantation.
    Lopez C; Simmons RL; Touraine JL; Park BH; Kiszkiss DF; Najarian JS; Good RA
    Clin Immunol Immunopathol; 1975 May; 4(1):135-42. PubMed ID: 1092496
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring and modulation of immune reactivity in human transplant recipients.
    Thomas F; Lee HM; Wolf JS; Mendez-Picon G; Thomas J
    Surgery; 1976 Apr; 79(4):408-13. PubMed ID: 769221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of T cell subset monitoring in cyclosporine-treated renal allograft recipients.
    Shen SY; Weir MR; Kosenko A; Revie DR; Ordonez JV; Dagher FJ; Chretien P; Sadler JH
    Transplantation; 1985 Dec; 40(6):620-3. PubMed ID: 3907032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte responsiveness in cancer and transplantation.
    McKhann CF; Slade MS; Gunnarsson A; Burk MW
    Transplant Proc; 1975 Jun; 7(2):287-90. PubMed ID: 1093297
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulocyte function in recipients of renal transplant from live related donors and from cadavers.
    Golshan N; Barker CF; MacGregor RR
    J Infect Dis; 1980 Dec; 142(6):876-83. PubMed ID: 7007525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1977 Apr; 28(1):123-9. PubMed ID: 140776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical patterns of renal allograft rejection.
    Flanigan WJ; Caldwell FT; Williams GD; Brewer TE; Glenn WE; Headstream JW; Campbell GS
    Ann Surg; 1971 May; 173(5):733-47. PubMed ID: 4933299
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive drugs used in clinical renal transplantation.
    Chatterjee SN
    Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
    [No Abstract]   [Full Text] [Related]  

  • 20. Histologic findings in acute renal allograft rejection with triple drug immunosuppressive therapy: a retrospective analysis.
    Moreno RF; Pallardo LM; Garcia J; Sanchez J; Rochera A; Cabezuelo J; de Agustin PP
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):5-6. PubMed ID: 3051590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.